Reference no: EM133606439

Question: You have been asked to investigate a new drug developed to relieve lower back pain. Please design an optimal intervention study (Phase III - clinical trial) and discuss its strengths and weaknesses. Background information: • About 10% of U.S. adults report having at least one episode of severe back pain that altered their daily activities for at least 5 days during the past year • About 3% of U.S. adults report having severe back pain during the past year that greatly altered their daily activities or ability to work for at least six weeks during the past year • For minor back pain, the current pharmaceutical treatment options reduce the pain score by 50% and decrease the days-of-work missed by 30% • For major back pain, the current pharmaceutical treatment options reduce the pain score by 20% and decrease the days-of-work missed by 10% a) Describe your selection of study participants. You should provide information about who, how many, and how allocated. (5 points) b) How would the treatment be administered in your experiment (you can assume the treatment is a pill) - What is administered, by whom, under what circumstances, etc.? (5 points) c) What outcome(s) would you collect